Brainstorm Cell Therapeu... Stock Price - BCLI

Best deals to access real time data!
Ultimate Trader (Monthly)
Monthly Subscription
for only
Small Cap Basic
Monthly Subscription
for only
Big Cap Pro
Monthly Subscription
for only
VAT not included
Last Trade
Last $ 3.90 ▲ 0.15 (4.00%)
Company Name Stock Ticker Symbol Market Type
Brainstorm Cell Therapeutics Inc BCLI NASDAQ Common Stock
  Price Change Change Percent Stock Price High Price Low Price Open Price Close Price Last Traded
  0.00 0.0% 3.75 0.00 0.00 0.00 3.75 07:10:37
Bid Price Ask Price Spread Spread % News
3.62 3.90 0.28 7.18% - -
Stock Trades Traded Volume Average Volume 52 Week Range
1 100 41,873 2.92 - 5.00
Last Trade Time Type Quantity Stock Price Currency
07:10:37 formt 100 $ 3.90 USD

Brainstorm Cell Therapeu... Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 84.77M 22.61M $ -13.95M -0.70 - 18.49M
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% 5.00 19.90%

more financials information »

Brainstorm Cell Therapeu... News

Loading Messages....

Latest BCLI Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical BCLI Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week3.783.883.363.7752,229-0.03-0.79%
1 Month3.974.153.363.7448,316-0.22-5.54%
3 Months3.644.153.363.8550,6500.113.02%
6 Months3.874.503.363.8688,632-0.12-3.1%
1 Year3.155.002.923.8176,6900.6019.05%
3 Years2.165.352.073.81107,9231.5973.61%
5 Years3.508.46671.904.28157,3330.257.14%

Brainstorm Cell Therapeu... Description

Brainstorm Cell Therapeutics Inc is a biotechnology company. The company is a developing novel adult stem cell therapies for debilitating neurodegenerative disorders such as Amyotrophic Lateral Sclerosis (ALS, also known as Lou Gehrig's disease), Multiple Sclerosis (MS), and Parkinson's disease (PD). Brainstorm's NurOwn, its proprietary process for the propagation of Mesenchymal Stem Cells (MSC) and differentiation into neurotrophic factor-(NTF) secreting cells (MSC-NTF), and their transplantation at, or near, the site of damage, offers the hope of more effectively treating neurodegenerative diseases.

Your Recent History
Gulf Keyst..
FTSE 100
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.